Melatonina Teva

Melatonin, the active ingredient in Melatonina Teva, is a melatonin receptor agonist presented as an oral formulation for oral use. It is employed to help regulate circadian rhythm and promote sleep onset in adults with insomnia or sleep‑wake rhythm disorders.

GNH USA supplies Melatonina Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonina Teva acts on melatonin receptors to address disorders of sleep regulation. - Insomnia: reduces sleep onset latency and improves sleep maintenance in adults. - Delayed sleep phase disorder: advances sleep timing and aligns circadian rhythm. - Non‑24‑hour sleep‑wake rhythm disorder: helps synchronize the sleep‑wake cycle in affected individuals.

Melatonina Teva may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness: transient light‑headedness. - Nausea: occasional stomach upset. - Daytime drowsiness: residual sleepiness. - Vivid dreams: unusual dream patterns. - Abdominal discomfort: mild cramps or pain.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Depression: worsening mood or suicidal thoughts. - Seizures: rare convulsive episodes. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm.

Before using Melatonina Teva, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: use with caution; limited information on excretion in milk. - Elderly patients: start with the lowest effective dose and monitor for excessive sedation. - Concomitant CNS depressants: may increase overall sedation; adjust therapy as needed. - Anticoagulant therapy: monitor for potential changes in bleeding risk. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Melatonina Teva can interact with several medication classes.

Major Interactions (Avoid): - Anticoagulants: may enhance bleeding tendency. - Immunosuppressants: could reduce immunosuppressive efficacy. - CYP1A2 inhibitors (e.g., fluvoxamine): increase melatonin plasma levels.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): additive sedative effect. - Antihypertensives: possible augmentation of blood‑pressure lowering. - Oral contraceptives: may alter hormone metabolism and efficacy.